MORGAN STANLEY PLC/CALL/STRYKER CORP./500/0.1/19.12.25 Share Price

Warrant

DE000MG0YH34

Real-time Bid/Ask 08:00:25 24/05/2024 pm IST
0.72 EUR / 0.76 EUR +1.37% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./500/0.1/19.12.25
1 month-15.12%
Date Price Change
24/24/24 0.72 -1.37%
23/24/23 0.73 +2.82%
22/24/22 0.71 +9.23%
21/24/21 0.65 -1.52%
20/24/20 0.66 -4.35%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 07:41 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MG0YH3
ISINDE000MG0YH34
Date issued 27/03/2024
Strike 500 $
Maturity 19/12/2025 (574 Days)
Parity 10 : 1
Emission price 0.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.45
Lowest since issue 0.65
Spread 0.05
Spread %6.58%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.1 USD
Average target price
372.4 USD
Spread / Average Target
+12.79%
Consensus